Key result
Microangiopathy linked to ~454% greater renal risk in diabetic patients.
Why the study?
Diabetic patients have a risk of kidney disease, leading to a need to assess the level of renal risk and identify associated predictive factors.
Cross-Sectional (n=320)
No
In a Togolese diabetic cohort, over half of patients had very significant renal risk, with male sex, microangiopathy, and beta-blocker use identified as risk factors, while RAS blockers and oral antidiabetics were protective.
Answers are grounded in this paper and cite their sources.
Microangiopathy may flag high renal risk in Togolese diabetics; leaves open causality and generalizability pending prospective data.
Background: Diabetic patients have risk of kidney disease. The aim of this study was to assess the level of renal risk in our study population and to identify the associated predictive factors. Methods: It was a descriptive and analytical cross-sectional study carried out over 5 years (January 1, 2016 to December 31, 2020). All patients were included regardless of the duration of diabetes and having achieved at least one serum creatinine and at least two (2) proteinuria in the 24 hours over a period of at least three months. The level of renal risk was assessed using the KDIGO 2012 classification. Results: A total of 320 patient medical files were retained. The sex ratio M/F was 1.2. The average age was 57.2 ± 11.8 years. Hypertension was the most common comorbidity (84.4%). Diabetic nephropathy was found in 177 patients, a frequency of 42.8%. The very significant renal risk was found in 174 patients (54.4%). In multivariate logistic regression, the risk factors significantly associated with renal risk were: Male sex (OR = 2.50; 95% CI = 1.29 - 4.84, p-value = 0.006); microangiopathy (OR = 5.54; 95% CI = 1.82 - 16.85 p = 0.002) and beta-blockers (OR = 5.64; 95% CI = 1.04 - 30.53 p = 0.004). The Oral Antidiabetes (OR = 0.23; 95% CI = 0.10 - 0.55, p = 0.001), the blockers of Renin-Angiotensin system (OR = 0.58; 95% CI = 0.41 - 0.90, p = 0.040) and the average socioeconomic level (OR = 0.50; 95% CI = 0.25 - 0.98, p = 0.044) were rather the protective factors.
No takes yet. Share an insight, caveat, or question.
Kodjo et al. (2022) conducted a cross-sectional in Diabetes (n=320). Microangiopathy vs. No microangiopathy was evaluated on Very significant renal risk (OR 5.54, 95% CI 1.82-16.85, p=0.002). In diabetic patients in Togo, microangiopathy was associated with a very high renal risk, whereas oral antidiabetics and renin-angiotensin system blockers were protective.
Synapse has enriched 10 related papers. Consider them for comparative context: